BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25809865)

  • 1. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
    Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.
    Song MA; Brasky TM; Marian C; Weng DY; Taslim C; Dumitrescu RG; Llanos AA; Freudenheim JL; Shields PG
    Epigenetics; 2015; 10(12):1177-87. PubMed ID: 26680018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.
    Quan L; Gong Z; Yao S; Bandera EV; Zirpoli G; Hwang H; Roberts M; Ciupak G; Davis W; Sucheston L; Pawlish K; Bovbjerg DH; Jandorf L; Cabasag C; Coignet JG; Ambrosone CB; Hong CC
    Int J Cancer; 2014 Mar; 134(6):1408-21. PubMed ID: 23996684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?
    Do WL; Conneely K; Gabram-Mendola S; Krishnamurti U; D'Angelo O; Miller-Kleinhenz J; Gogineni K; Torres M; McCullough LE
    Breast Cancer Res Treat; 2020 May; 181(1):135-144. PubMed ID: 32236829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry.
    Ambrosone CB; Young AC; Sucheston LE; Wang D; Yan L; Liu S; Tang L; Hu Q; Freudenheim JL; Shields PG; Morrison CD; Demissie K; Higgins MJ
    Oncotarget; 2014 Jan; 5(1):237-48. PubMed ID: 24368439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race and the prognostic influence of p53 in women with breast cancer.
    Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
    Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.
    Conway K; Edmiston SN; May R; Kuan PF; Chu H; Bryant C; Tse CK; Swift-Scanlan T; Geradts J; Troester MA; Millikan RC
    Breast Cancer Res; 2014 Oct; 16(5):450. PubMed ID: 25287138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry.
    Gong Z; Chen J; Wang J; Liu S; Ambrosone CB; Higgins MJ
    PLoS One; 2021; 16(3):e0249229. PubMed ID: 33784351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome.
    Lund MJ; Mosunjac M; Davis KM; Gabram-Mendola S; Rizzo M; Bumpers HL; Hearn S; Zelnak A; Styblo T; O'Regan RM
    Cancer; 2012 Feb; 118(3):788-96. PubMed ID: 21720988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
    Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
    Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
    Vallega KA; Liu N; Myers JS; Yu K; Sang QX
    PLoS One; 2016; 11(6):e0157741. PubMed ID: 27314854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African American patients with breast cancer have worse prognosis than white patients in certain subtypes and stages.
    Arciero CA; Yang J; Peng L; Ward KC; O'Regan R; Sahin AA; Li X
    Breast Cancer Res Treat; 2017 Dec; 166(3):743-755. PubMed ID: 28856481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel age-associated DNA methylation changes and epigenetic age acceleration in middle-aged African Americans and whites.
    Tajuddin SM; Hernandez DG; Chen BH; Noren Hooten N; Mode NA; Nalls MA; Singleton AB; Ejiogu N; Chitrala KN; Zonderman AB; Evans MK
    Clin Epigenetics; 2019 Aug; 11(1):119. PubMed ID: 31426852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
    Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
    JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status.
    Cunningham JE; Montero AJ; Garrett-Mayer E; Berkel HJ; Ely B
    Cancer Causes Control; 2010 Mar; 21(3):399-409. PubMed ID: 20024610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women?
    Espinal AC; Buas MF; Wang D; Cheng DT; Sucheston-Campbell L; Hu Q; Yan L; Payne-Ondracek R; Cortes E; Tang L; Gong Z; Zirpoli G; Khoury T; Yao S; Omilian A; Demissie K; Bandera EV; Liu S; Ambrosone CB; Higgins MJ
    Breast Cancer Res Treat; 2017 Nov; 166(2):559-568. PubMed ID: 28756535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study.
    Parada H; Sun X; Fleming JM; Williams-DeVane CR; Kirk EL; Olsson LT; Perou CM; Olshan AF; Troester MA
    Breast Cancer Res; 2017 Dec; 19(1):131. PubMed ID: 29228969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants of estrogen-related genes and breast cancer risk in European and African American women.
    Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S
    Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.
    Sunami E; Shinozaki M; Sim MS; Nguyen SL; Vu AT; Giuliano AE; Hoon DS
    Breast Cancer Res; 2008; 10(3):R46. PubMed ID: 18485221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.